Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05158153 · ClinicalTrials.gov registry record · Phase 4
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis
A Phase 4 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT05158153: Clinical Trial Phase 4 study, sponsored by University of California, San Francisco.
NCT05158153 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 1 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05158153, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
There are currently no therapies to improve the chances of recovering enough kidney function to come off of dialysis after severe acute kidney injury. It is not known if current routine outpatient dialysis treatments are optimized to maximize the chances of recovery. The purpose of this pilot study is to see if we can feasibly and safely provide several changes to the way that dialysis is provided in outpatient dialysis centers which may improve the chances of recovery.
Primary Outcome
Feasibility
Interventions
- DRUG Furosemide
- OTHER ORKID Bundled Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2022-04-19 |
| Phase | Phase 4 |
Why NCT05158153 stopped before completion
NCT05158153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Furosemide is the first listed.
NCT05158153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05158153 about?
NCT05158153 is a clinical study titled "Outpatient Recovery From Acute Kidney Injury Requiring Dialysis". There are currently no therapies to improve the chances of recovering enough kidney function to come off of dialysis after severe acute kidney injury. It is not known if current routine outpatient dialysis treatments are optimized to maximize the chances of recovery. The purpose of this pilot study ...
What is the current status of trial NCT05158153?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2021-10-18. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT05158153?
The interventions under investigation include: Furosemide (DRUG), ORKID Bundled Intervention (OTHER).
Who is sponsoring clinical trial NCT05158153?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05158153's enrollment target sits among peer trials
1 2000th of 2000 the lowest of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI